IV push (IVP) — also called intravenous push, IV bolus, or direct IV injection — is the administration of a medication directly into the bloodstream through an existing venous access device using a syringe. The drug enters circulation immediately, bypasses gastrointestinal absorption and first-pass metabolism, and reaches therapeutic levels in minutes. That speed is precisely why IV push requires more preparation, more verification, and more monitoring than any other medication route.
Quick reference: IV push vs. IVPB vs. primary infusion
| Feature | IV push | IV piggyback (IVPB) | Primary infusion |
|---|---|---|---|
| Volume | 1–20 mL (syringe) | 50–250 mL (mini-bag) | 250–1,000+ mL |
| Duration | Seconds to 10 min | 15–90 min | Continuous |
| Onset | Fastest | Intermediate | Slowest |
| Fluid load | Minimal | Moderate | Variable |
| Nurse time | Short (active, at bedside) | Set and monitor | Set and monitor |
| Error retrievability | None | Limited | Limited |
For IV piggyback setup, back-check valves, and antibiotic timing, see IV piggyback nursing. This article focuses on direct IV push bolus technique, rate guidelines, the SASH and SAS flush protocols, and the clinical decisions involved in safe IV push administration.
When IV push is used
IV push is the route of choice when speed is the therapeutic goal or when IV piggyback is impractical:
- Emergency situations — adenosine for SVT termination, atropine for symptomatic bradycardia, epinephrine during resuscitation, naloxone for opioid reversal
- Diuresis — furosemide for acute fluid overload in heart failure or pulmonary edema
- Pain management — morphine, hydromorphone, and ketorolac when rapid analgesia is needed
- Nausea — ondansetron, metoclopramide, prochlorperazine
- Rate control — metoprolol or diltiazem for atrial fibrillation with rapid ventricular response
- Fluid restriction — patients who cannot tolerate additional fluid volume (acute decompensated heart failure, end-stage renal disease) benefit from IV push because no diluent bag is required
- NPO status or absorption impairment — the gastrointestinal route is unavailable or unreliable
IV push is appropriate when a medication has a short half-life that demands precise timing (adenosine, 10 seconds), when the clinical scenario requires immediate effect (emergency or urgent situations), or when the IV piggyback route would require volume the patient cannot receive.
Safety framework before any IV push
Eight rights of medication administration
Before drawing up any IV push medication, verify all eight rights — do not abbreviate this process because the route is intravenous:
- Right patient — two identifiers (name and date of birth, or name and MRN per facility policy)
- Right medication — read the label three times: when pulling the medication, when drawing it up, and before administration
- Right dose — calculate independently; do not rely on the pre-drawn syringe label alone
- Right route — confirm IV is ordered and the patient has a patent venous access device
- Right time — administer within the facility’s window of the scheduled time; for rate-sensitive drugs, administer exactly per rate guidelines
- Right documentation — document immediately after administration, not in advance
- Right reason — know the clinical indication; know why this patient is receiving this drug now
- Right response — know what the drug should do and what adverse effects to watch for; monitor after administration
For a complete medication administration framework, see medication rights nursing.
Pre-administration checks
Review the medication. Consult a drug reference for the IV push dose, rate, dilution requirements, onset, peak, duration, contraindications, and monitoring parameters. Do not administer IV push medications without knowing the rate — guessing is a safety violation.
Check compatibility. If the patient has an existing primary IV infusion running, confirm the IV push medication is compatible with that solution. Incompatibilities fall into three categories:
- Physical: A visible precipitate forms, making the solution unsafe to administer
- Chemical: Degradation occurs without visible change, reducing drug efficacy or producing toxic byproducts
- Therapeutic: Two drugs with opposing pharmacological effects are given together
If compatibility is uncertain, stop the primary infusion and flush the line with normal saline before administering the IV push medication. Resume the primary infusion after the push and a post-flush.
Assess the IV site. Before administering any IV push medication:
- Inspect the insertion site for redness, swelling, induration, or tenderness
- Aspirate for blood return (brisk, bright red blood return confirms intravascular placement in a peripheral IV — absence of blood return does not confirm infiltration, but presence confirms patency)
- Flush with 2–5 mL normal saline and observe; infiltration produces swelling at the site and the patient reports pain or coolness
- Do not administer IV push medications through an IV site that shows signs of infiltration or extravasation
For peripheral IV insertion technique and site assessment, see IV insertion.
Select the right port. On a primary IV line, administer IV push medications through the port closest to the patient — not the port closest to the IV bag. This minimizes the amount of primary infusion fluid the medication must displace before reaching the patient.
Flush protocols: SASH and SAS
All IV push medications require flushing before and after administration. The flush protocol depends on the type of venous access device:
SASH (for heparin-locked central lines and PICCs)
- S — Saline flush (10 mL normal saline, push-pause technique)
- A — Administer the medication
- S — Saline flush (10 mL normal saline, push-pause technique, at the same rate as the medication)
- H — Heparin lock (concentration and volume per facility policy, typically 10–100 units/mL)
SAS (for peripheral IV access or saline-locked lines)
- S — Saline flush (2–5 mL normal saline for peripheral IV; 10 mL for central access)
- A — Administer the medication
- S — Saline flush (same volume as the pre-flush, at the same rate as the medication)
Rate the post-flush identically to the medication. Administering the saline flush faster than the medication drives any residual drug from the line into circulation at an accelerated rate — producing the same effect as a speed error on the drug itself.
Scrub the hub. Before accessing any IV port, perform a vigorous 5-second alcohol scrub of the needleless connector or hub and allow it to dry completely. Failure to scrub before each access is one of the leading causes of IV-related bloodstream infections.
IV push administration technique: step by step
Preparation (at the medication room)
- Perform hand hygiene.
- Verify the order and the eight rights.
- Look up the drug rate in a current drug reference. Note the dose, rate (per minute or per seconds), and any dilution requirements.
- Draw up the medication using the smallest syringe appropriate for the volume. Label the syringe immediately with the drug name, dose, concentration, and date/time.
- Draw up two saline flush syringes — one for the pre-flush, one for the post-flush.
- Transport medications safely in a labeled container.
At the bedside
- Verify patient identity using two identifiers.
- Explain the procedure — what you are giving, what it is for, and what the patient may feel.
- Position the patient appropriately for the medication (e.g., supine for morphine due to orthostatic risk; sitting up for metoprolol so you can monitor blood pressure easily).
- Assess the IV site (inspect, flush with saline, confirm patency as above).
- Stop or pause the primary IV infusion if compatibility with the push medication is in question.
- Scrub the hub — vigorous 5-second alcohol scrub, allow to dry.
- Administer the pre-flush — 2–5 mL (peripheral) or 10 mL (central) normal saline at a moderate pace; observe the site.
Administering the medication
- Attach the medication syringe to the port.
- Use a watch or clock with a second hand to control the rate. Divide the total volume by the required time to determine how many mL to push per minute or per 10-second interval.
- Administer at the prescribed rate. Do not rush IV push medications. Rate guidelines exist because cardiovascular and neurological systems respond to peak concentration — administering too fast creates dangerous peaks.
- Monitor the patient during administration. Watch for flushing, diaphoresis, chest tightness, or changes in respiratory rate. For cardiac medications, monitor the cardiac monitor during and after the push.
- Administer the post-flush at the same rate as the medication.
- Lock or reconnect the line per the SASH or SAS protocol.
- Monitor the patient for the expected response and for adverse effects — the time window is drug-specific (see table below).
- Document the medication, dose, route, time, and patient response.
Common IV push medications and rate guidelines
Rate guidelines represent the minimum safe administration time. Administering faster than the listed rate risks speed shock, cardiovascular toxicity, or organ-specific adverse effects. Always verify rates in a current drug reference and against facility policy before administering.
Table 2 — Common IV push medications: rates and key nursing considerations
| Medication | Common IV push dose | Rate | Key nursing monitoring |
|---|---|---|---|
| Furosemide (Lasix) | 20–80 mg | 20 mg/min; doses >120 mg: no faster than 4 mg/min | Ototoxicity risk with rapid administration or high doses; monitor urine output, BMP |
| Morphine sulfate | 2–4 mg | Over 4–5 min (approximately 1 mg/min) | Respiratory depression, hypotension, sedation; have naloxone available |
| Hydromorphone (Dilaudid) | 0.2–1 mg | Over 2–5 min | More potent than morphine mg-for-mg; monitor respiratory rate |
| Ondansetron (Zofran) | 4–8 mg | Over 2–5 min (not less than 30 sec) | QTc prolongation risk; avoid in patients with baseline QT prolongation or on QT-prolonging drugs |
| Metoprolol tartrate | 5 mg | Over 1–2 min; repeat every 5 min up to 15 mg if needed | Monitor HR, BP, and cardiac rhythm; hold if HR <60 or SBP <90; have atropine available |
| Diltiazem | 0.25 mg/kg (max 20 mg first dose) | Over 2 min | Continuous cardiac monitoring required; monitor for hypotension, bradycardia |
| Adenosine | 6 mg (first dose); 12 mg (if needed) | Over 1–2 seconds — as fast as possible, followed immediately by 20 mL rapid saline flush | Must be given rapidly — very short half-life (~10 sec). Patient will feel transient chest tightness, flushing, or sense of doom. Inform patient beforehand. Continuous cardiac monitoring mandatory |
| Lorazepam (Ativan) | 0.02–0.04 mg/kg (max 4 mg) | Over 2 min | Monitor respiratory rate and sedation; have resuscitation equipment available |
| Ketorolac (Toradol) | 15–30 mg | Over 15 seconds minimum | Assess renal function; limit to 5 days cumulative IV/IM; assess for GI risk |
| Naloxone (Narcan) | 0.04–0.4 mg | Over 30 seconds to 2 min; titrate to effect | Onset 1–2 min; re-sedation risk if opioid half-life exceeds naloxone — monitor for at least 2 hours |
Adenosine special consideration. Adenosine has a half-life of approximately 10 seconds. It must be given as fast as possible — over 1–2 seconds — through the most proximal IV site (antecubital preferred, not hand or wrist). Immediately after the drug syringe, push 20 mL normal saline rapidly. The flush drives the medication to central circulation before the drug is metabolized. Warn the patient before administration: the transient chest pressure, flushing, and sense of impending doom are expected and resolve within 30 seconds.
Recognizing and responding to complications
Speed shock. Administering IV push medication too rapidly introduces a drug bolus that exceeds the cardiovascular system’s ability to buffer it. Signs: facial flushing, chest tightness, irregular pulse, diaphoresis, hypotension, cardiac arrest in severe cases. Prevention is the intervention — know and follow the rate. If speed shock is suspected, stop the infusion and call for help immediately.
Extravasation. Occurs when a vesicant or irritant medication leaks into the surrounding tissue. Recognize it by pain, burning, swelling, and coolness at the IV site during administration. Stop immediately. Do not flush the line — this drives more drug into the tissue. Follow your facility’s extravasation protocol; some agents require antidote injection into the affected tissue. For vesicant medications (certain chemotherapy agents, concentrated potassium, dopamine), use a central venous catheter rather than a peripheral IV whenever possible.
Infiltration. Occurs when non-vesicant fluid or medication enters subcutaneous tissue. The site becomes swollen, cool, and pale. Stop the infusion. Remove the peripheral IV and start a new site.
Phlebitis. Inflammation of the vein wall, caused by mechanical irritation (catheter movement), chemical irritation (medication pH or osmolality), or infection. Signs: erythema, warmth, tenderness, and a palpable cord along the vein. Grade phlebitis using the VIP scale (Visual Infusion Phlebitis) and follow facility policy for removal and re-siting.
Medication calculation fundamentals
IV push rate problems are common on NCLEX. The standard approach:
- Identify the drug dose in the syringe and the total volume
- Identify the required administration time from the drug reference or order
- Calculate mL per minute: volume (mL) ÷ time (min) = mL/min
- For very fast drugs (adenosine): administer the entire volume over the prescribed seconds — no calculation needed, just speed
Example: Furosemide 40 mg/4 mL ordered. Administer at 20 mg/min.
- Time = 40 mg ÷ 20 mg/min = 2 minutes
- Rate = 4 mL ÷ 2 min = 2 mL/min
For complete IV drug calculation practice, see medication calculation nursing.
Common mistakes
Failing to check the rate before administration. IV push medication rates are not optional. Administering without rate verification — even for a drug you think you know — is a medication error waiting to happen.
Administering the post-flush faster than the medication. This effectively accelerates the delivery of residual drug from the line, creating a speed error on the tail end of the dose.
Not scrubbing the hub. The needleless connector is the most common entry point for pathogens in IV-related bloodstream infections. A five-second vigorous scrub before every access is non-negotiable.
Using a small syringe to forcefully flush a resistant line. Small syringes generate high PSI. Never force a flush against resistance — this can dislodge a clot into the bloodstream. Stop, assess the line, and troubleshoot. Do not increase force.
Ignoring the IV site during administration. The nurse must observe the insertion site throughout IV push administration, not just before. Extravasation can begin during the push itself.
Skipping pre-medication assessment. Every IV push requires a pre-administration assessment that establishes a baseline. For metoprolol: HR and BP before every dose. For morphine: pain score, respiratory rate, sedation level. Treating without a baseline means you cannot determine whether the medication worked or caused harm.
NCLEX tips
- IV push delivers medication directly into the bloodstream — onset is minutes to seconds depending on circulation time
- SASH = Saline, Administer, Saline, Heparin — for heparin-locked lines and PICCs
- SAS = Saline, Administer, Saline — for peripheral IV or saline-locked lines
- Post-flush must be administered at the same rate as the medication
- Adenosine must be given over 1–2 seconds and followed immediately by a 20 mL rapid saline flush — it has a ~10-second half-life
- Furosemide >120 mg: rate must not exceed 4 mg/min to prevent ototoxicity
- Speed shock = too-fast administration; signs include flushing, chest tightness, irregular pulse
- Scrub the hub for 5 seconds before every IV access
- Select the proximal port (closest to patient) on a Y-site for IV push medications
- Blood return confirms patency — absence of return does not confirm infiltration, but presence confirms vessel placement
- For IV push through a running primary line: confirm compatibility; if uncertain, stop primary, flush, push, flush, then restart
- Syringe size matters for central lines: use 10 mL or larger to stay within safe pressure limits
- Extravasation = stop immediately; do not flush; call for extravasation protocol
NCLEX scenarios
Scenario 1
A nurse is preparing to administer furosemide 80 mg IV push. The medication is supplied as 10 mg/mL in a 10 mL vial. What is the correct administration time?
Answer: 80 mg ÷ 20 mg/min = 4 minutes minimum. The nurse draws up 8 mL (80 mg at 10 mg/mL) and administers it over at least 4 minutes, at a rate of 2 mL/min.
Scenario 2
A nurse prepares to give IV push ondansetron to a patient who is also receiving a continuous normal saline infusion. Which action is correct?
A. Administer the ondansetron into the port closest to the IV bag. B. Stop the saline infusion before administering the ondansetron. C. Administer the ondansetron through the port closest to the patient and allow the saline to run simultaneously. D. Dilute the ondansetron in 50 mL saline before administering.
Answer: C. Ondansetron is compatible with normal saline. The nurse selects the proximal port (closest to the patient) on the Y-site and may allow the primary infusion to run simultaneously. Administering through the proximal port ensures the medication reaches the patient quickly and that flush volume from the primary infusion helps clear the drug from the line.
Scenario 3
A patient in SVT requires adenosine 6 mg IV push. Which action by the nurse is most important?
A. Administer over 5 minutes to prevent speed shock. B. Administer through a hand IV and flush slowly. C. Administer as rapidly as possible over 1–2 seconds and follow immediately with a 20 mL rapid saline flush. D. Dilute in 10 mL saline before administration.
Answer: C. Adenosine has an extremely short half-life (~10 seconds) and must be administered as rapidly as possible and followed by a 20 mL rapid saline flush to push it to central circulation before it is metabolized. It should be given through an antecubital or more central site when possible.
Scenario 4
During IV push administration of morphine, the nurse observes that the IV site is cool, swollen, and the patient reports a burning sensation at the insertion point. What is the priority action?
Answer: Stop the infusion immediately. This presentation — coolness, swelling, burning — is consistent with infiltration or extravasation. Assess whether morphine is a vesicant at the ordered concentration. Do not flush the line. Remove the peripheral IV, apply appropriate therapy per extravasation or infiltration protocol, and start a new IV site before resuming analgesic therapy.
Scenario 5
A nurse administers metoprolol 5 mg IV push and then flushes the line quickly with 5 mL saline in 10 seconds. The patient’s blood pressure drops from 118/72 to 88/54 mmHg. What likely occurred?
Answer: The rapid saline flush accelerated residual metoprolol from the IV line into the circulation — effectively delivering a faster dose than ordered. The post-flush must always be administered at the same rate as the medication. The nurse should position the patient flat, monitor vital signs and cardiac rhythm, notify the provider, and be prepared to administer IV fluids or vasopressors per standing orders.
Related skills
- IV piggyback nursing — IVPB setup, bag height, back-check valve mechanics, antibiotic timing, and IVPB vs. IV push decision points
- IV insertion — peripheral IV cannulation technique, site selection, and catheter securement
- Medication rights nursing — the eight rights framework and systematic safety checks before any medication administration
- Medication calculation nursing — dimensional analysis, dose calculation, and IV rate problems